Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

Delayed Quote. Delayed  - 07/26 10:00:00 pm
0.441 USD   -2.52%
01:06p Galena Biopharma to Report Second Quarter 2016 Financial Results ..
07/13 Galena Biopharma Announces Closing of Registered Direct Offering
07/08 Galena Biopharma to Host Webcast and Conference Call Today
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/20/2016 07/21/2016 07/22/2016 07/25/2016 07/26/2016 Date
0.4855(c) 0.47(c) 0.45(c) 0.4524(c) 0.441(c) Last
21 462 539 21 959 374 6 009 849 3 610 629 2 932 384 Volume
+27.39% -3.19% -4.26% +0.53% -2.52% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -36,0 M
Net income 2016 -51,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -33,8 M
Net income 2017 -38,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 94,9 M
More Financials
Company
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating : -
More Ratings
Latest news on GALENA BIOPHARMA INC
01:06p Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide ..
07/18 GALENA BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (fo..
07/18 GALENA BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Financial S..
07/13 Galena Biopharma Announces Closing of Registered Direct Offering
07/12 GALENA BIOPHARMA, INC. : Unregistered Sale of Equity Securities (form 8-K)
07/08 GALENA BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Results of ..
07/08 Galena Biopharma to Host Webcast and Conference Call Today
07/08 Galena Biopharma Announces Pricing of Registered Direct Offering
07/06 GALENA BIOPHARMA INC : Four Companies to Watch in This Bullish Market
06/29 WEDNESDAY SECTOR LAGGARDS : Biotechnology, Waste Management Stocks
More news
Sector news : Pharmaceuticals - NEC
03:51p Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
01:45pDJEli Lilly Revenue Rise Helped by New Products
01:40pDJELI LILLY : Revenue Helped by Sales of New Drugs
09:25a Takeda sets bidding deadline for chemical firm stake, CVC and Carlyle may bid..
07/25DJSTADA ARZNEIMITTEL : Feels More Heat From Active Ownership
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/12 Galena issues over 3.6M shares of stock to resolve outstanding issues
07/08 Galena Biopharma's (GALE) CEO Mark Schwartz on Business Update Call Transcrip..
07/08 Galena inks direct placement of shares at $0.45
07/06 Biotechnology - The Perfect Yo-Yo
07/01 BIOTECH FORUM DAILY DIGEST : Tesaro's Huge Week! Brexit Losses Gone, Spotlight O..
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 1,47 $
Spread / Average Target 224%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark W. Schwartz President, Chief Executive Officer & Director
Sanford J. Hillsberg Chairman
Gavin S. Choy Senior VP-Clinical Sciences & Operations
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC-69.39%95
JOHNSON & JOHNSON21.58%343 528
PFIZER INC.13.94%223 065
NOVARTIS AG-5.13%218 815
ROCHE HOLDING LTD.-9.62%217 668
MERCK & CO., INC.10.87%162 096
More Results